Allergy Therapeutics (AGYTF)

Last Closing Price: --

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Allergy Therapeutics (AGYTF) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$53.99M
$21.40M
$39.45M
$93.44M
$33.84M
$54.50M
$68.75M
$102.59M
$-9.16M
$-14.94M
$-9.16M
--
Cash Flow Statement Financials
$-9.87M
$-1.81M
$22.76M
$16.54M
$27.76M
$11.22M
$-0.13M
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Receiveable Turnover
--
--
--
--
--
--
--
--
--